statine has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 1 studies
Studies (statine) | Trials (statine) | Recent Studies (post-2010) (statine) | Studies (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Trials (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) |
---|---|---|---|---|---|
128 | 6 | 40 | 792 | 16 | 476 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gourni, E; Jamous, M; Maecke, HR; Mansi, R; Reubi, JC; Tamma, ML; Waser, B | 1 |
1 other study(ies) available for statine and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Article | Year |
---|---|
PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists.
Topics: Amino Acids; Animals; Biological Transport; Bombesin; Cell Line, Tumor; Chelating Agents; Drug Stability; Female; Fluorenes; Heterocyclic Compounds, 1-Ring; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Polyethylene Glycols; Receptors, Bombesin; Structure-Activity Relationship; Tissue Distribution | 2014 |